T-lymphotrophic virus

Details T-lymphotrophic virus T-lymphotrophic virus

A - Human Necessities

61

K

167/130, 167/37

A61K 39/12 (2006.01) C07K 14/16 (2006.01) C12Q 1/70 (2006.01) G01N 33/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 1270756

T-LYMPHOTROPHIC VIRUS Abstract of the Disclosure A substantially pure polypeptide having at least one antigenic determinant that is substantially identical to an antigenic determinant of a protein from a cell line infected with simian T-lymphotrophic virus-III or human T-lymphotrophic virus-IV (HTLV-IV), the protein being selected from: a) a glycoprotein having a molecular weight (m.w.) of about 160,000 daltons; a glycoprotein having a m.w. of about 120,000 daltons; a gag protein having a m.w. of about 55,000 daltons; a gag protein having a m.w. of about 24,000 daltons; and a glycoprotein having a m.w. of about 32,000 daltons. also disclosed are various methods of immunoassay using that peptide or antibodies raised to it. Finally, immunoassays for simian specimens are disclosed using peptides that are immunologically cross-reactive with the above-described peptide, or antibodies thereto. - 21 -

522845

Affiliated with

Also associated with

Rating

T-lymphotrophic virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with T-lymphotrophic virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T-lymphotrophic virus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1324786